Iconix Brand Group, Inc. (Nasdaq: ICON) ("Iconix" or the "Company") today reported financial results for the fourth quarter and full year ended December 31, 2020.

Bob Galvin, CEO commented, “Our entire organization committed to delivering the best possible results for our licensees and our shareholders this past year and I want to thank each of our associates for their dedication during this very difficult period. We operated at a high level throughout the pandemic due to our consistent focus on our business objectives. While we are hopeful that the pandemic will subside in 2021, we will continue to address the many pandemic-related challenges we face between now and then, and, at the same time, continue to focus on realizing the opportunity that exists for our brands through focusing on building our pipeline of future business. We had great success during this pandemic year, as we signed 190 deals for aggregate guaranteed minimum royalties of approximately $134 million, approximately the same amount that we signed in 2019.

Galvin continued, “We have also made great strides to de-lever our balance sheet. From December 31, 2019 to today, through proceeds from assets sales and cash flow, we have reduced our Term Loan balance by over 52%, or approximately $92 million.”

Fourth Quarter & Full Year 2020 Financial Results

GAAP Revenue by Segment(000’s)

    For the Three MonthsEnded December 31,   For the Twelve MonthsEnded December 31,
    2020   2019   2020   2019
Licensing revenue:                
Women's   $ 8,443   $ 10,637   $ 25,248   $ 37,491
Men's     7,318     11,302     22,737     36,793
Home     5,758     3,548     16,194     14,753
International     12,369     17,691     44,397     59,947
    $ 33,888   $ 43,178   $ 108,576   $ 148,984

For the fourth quarter of 2020, total revenue was $33.9 million, a 22% decline, compared to $43.2 million in the fourth quarter of 2019. Revenue across all segments, except our Home segment, was primarily negatively impacted by the effects of the COVID-19 pandemic on the global economy. The 21% decrease in revenue in our Women’s segment was principally as a result of a decrease in licensing revenue from our Mudd and London Fog brands partially offset by an increase in our Danskin Brand. Revenue from the Men’s segment decreased 35% mainly due to a decrease in licensing revenue from our Buffalo and Ecko Unltd brands partly offset by an increase in our Umbro brand. Sales in our Home segment improved by 62% principally due to an increase in licensing revenue from our Charisma and Cannon brands, partially offset by a decrease in our Fieldcrest brand. Our International segment revenue declined 30% mainly due to decreases in Latin America and Europe.

For the twelve months ended December 31, 2020, total revenue was $108.6 million, a 27% decline, compared to $149.0 million in the twelve months ended December 31, 2019. The decrease was primarily driven by decreases in our Woman’s, Men’s and International segments as a result of the negative impacts of the COVID-19 pandemic on the global economy.

SG&A Expenses:Total SG&A expenses in the fourth quarter of 2020 were $17.4 million, a 27% decline compared to $23.9 million in the fourth quarter of 2019. The decline for the quarter was primarily driven by a decrease in professional fees, advertising costs and bad debt expense.

Total SG&A expenses in the twelve months ended December 31, 2020 were $59.4 million, a 30% decline compared to $84.7 million in the twelve months ended December 31, 2019, as we have aligned our costs to the current business level. The decline was primarily due to decreases in advertising expense, compensation costs and professional fees.

Trademark, Investment and Asset Impairment:In the fourth quarter of 2020, the Company recorded a non-cash trademark impairment charge of $11.3 million. The charge for the fourth quarter of 2020 was mostly based on the current and estimated future cash flows on the fair value of the Candies and Rampage indefinite-lived trademarks. The Company recorded investment impairments of $2.4 million in the fourth quarter of 2020 as a result of a reduction in the fair value of our Candies joint venture in China. In the fourth quarter of 2019, the Company recorded a non-cash trademark impairment charge of $65.6 million, primarily related to the write-down in the Joe Boxer and Mudd trademarks in the Women’s segment and Fieldcrest in the Home segment. The Company also recorded a non-cash investment impairment charge of $9.6 million in the fourth quarter of 2019 due to impairment of the Company’s investment in MG Icon, which owns the Material Girl trademark, and an asset impairment charge of $1.8 million related to the consolidation and partial sublease of our New York office space.

Total trademark, investment and asset impairment for the twelve months ended December 31, 2020 was $54.7 million as compared to $94.0 million for the twelve months ended December 31, 2019.

Operating Income and Adjusted EBITDA (1):

Adjusted EBITDA is a non-GAAP metric, and a reconciliation table is included below.

Operating income for the fourth quarter of 2020 was $2.6 million, as compared to operating loss of $60.4 million for the fourth quarter of 2019.  The fourth quarter 2020 results include $13.8 million of charges related to impairments. Adjusted EBITDA in the fourth quarter of 2020 was $18.4 million, which represents operating income of $2.6 million excluding net adjustments of $15.8 million. Adjusted EBITDA in the fourth quarter of 2019 was $21.1 million, which represents operating loss of $60.4 million excluding net charges of $81.5 million. The change period over period in Adjusted EBITDA was primarily as a result of reduced revenue largely driven by the impact of the COVID-19 pandemic on our business, somewhat offset by reduced expenses driven by the Company’s cost reduction initiative. Refer to footnote 1 below for a full detailed reconciliation of operating income to Adjusted EBITDA.      

Note: All items in the following tables are attributable to the Company’s interest in its subsidiaries and joint ventures, as applicable, and exclude the results related to any non-controlling interest in such entities. Certain numbers may not add due to rounding.

Adjusted EBITDA by Segment (1) For the Three Months Ended December 31,       For the Year Ended December 31,  
(000's) 2020   2019   % Change       2020   2019   % Change  
                                         
Women's $ 6,880   $ 9,139     -25 %     $ 23,332   $ 35,493     -34 %
Men's   4,543     4,778     -5 %       10,400     15,625     -33 %
Home   4,974     3,081     61 %       14,644     12,871     14 %
International   7,367     11,247     -34 %       25,036     37,567     -33 %
Corporate   (5,382 )   (7,145 )   25 %       (18,279 )   (20,785 )   12 %
Adjusted EBITDA $ 18,382   $ 21,100     -13 %     $ 55,133   $ 80,771     -32 %
                                         
Adjusted EBITDA Margin (2)   54 %   49 %             51 %   54 %      

Adjusted EBITDA margin in the fourth quarter of 2020 was 54% as compared to Adjusted EBITDA margin in the fourth quarter of 2019 of 49%. The change period over period in Adjusted EBITDA margin is primarily a result of the Company’s expenses decreasing at a faster rate than revenue.

Interest Expense and Other Loss, net:

Interest expense in the fourth quarter of 2020 was $15.4 million as compared to $13.5 million in the fourth quarter of 2019. The legal final maturity date of the Securitization Notes is in January of 2043. The Company did not repay or refinance the Securitization Notes prior to the anticipated repayment date. Therefore, beginning January 2020, the Company accrues additional interest on the Securitization Notes that is not payable until 2043. The increase in interest expense period over period was primarily the result of the step up in interest for the securitization. In the fourth quarter of 2020, Other loss was $1.7 million as compared to a loss of $12.1 million in the fourth quarter of 2019. This result is primarily from the Company's accounting for the 5.75% Convertible Notes, which requires recording the fair value of this debt at the end of each period with any change from the prior period accounted for as other income or loss in the respective period's consolidated income statement.

Interest expense in the twelve months ended December 31, 2020 was $67.7 million as compared to $56.9 million for the twelve months ended December 31, 2019. For Other loss, net for the twelve months ended December 31, 2020, the Company recognized a $3.6 million loss as compared to a $5.3 million in the prior year period.

Provision for Income Taxes:

The effective income tax rate for the fourth quarter of 2020 was 14.4%, which resulted in a $2.2 million income tax benefit, as compared to an effective income tax rate of -5.1% in the fourth quarter of 2019, which resulted in a $4.4 million income tax expense.  The income tax benefit for the fourth quarter of 2020, was primarily driven by a decrease in foreign taxes and a consolidated pretax loss for the quarter. The income tax expense for the fourth quarter of 2019 was primarily driven by the increase in foreign withholding taxes.

The effective tax rate for the twelve months ended December 31, 2020 was 42.6%, which resulted in a 2.2 million tax benefit as compared to an effective income tax rate of -6.0% for the twelve months ended December 31, 2019, which resulted in a $5.7 million tax expense. The increase in the effective tax rate was primarily due to a $6.7 million tax benefit generated during the current year related to the CARES Act which was calculated against a pre-tax loss as compared to the prior year where the Company calculated a current tax expense due to foreign withholding taxes calculated against a pre-tax loss.

GAAP Net Loss and GAAP Diluted EPS:

GAAP net loss attributable to Iconix for the fourth quarter of 2020 reflected a net loss of $14.1 million, compared to a net loss of $93.0 million for the fourth quarter of 2019. GAAP diluted EPS for the fourth quarter of 2020 reflected a loss of $1.06 per share, compared to a loss of $7.94 per share for the fourth quarter of 2019.

GAAP net loss attributable to Iconix for the twelve months ended December 31, 2020 reflected a net loss of $7.3 million, compared to a net loss of $109.5 million for the twelve months ended December 31, 2019. GAAP diluted EPS for the twelve months ended December 31, 2020 reflected a loss of $0.60 per share compared to a loss of $10.37 per share for the twelve months ended December 31, 2019.

Adjusted EBITDA (1):

Adjusted EBITDA for the fourth quarter of 2020 was $18.4 million, compared to $21.1 million for the fourth quarter of 2019.

Adjusted EBITDA: (1)        
(000's)        
  For the Three Months Ended December 31,  
    2020     2019   % Change  
         
GAAP Operating Income (Loss) $ 2,553   $ (60,388 )    
Add:        
stock-based compensation expense   196     209      
depreciation and amortization   302     423      
contract asset write offs, net   137     136      
impairment charges   13,768     76,966      
special charges   2,513     4,805      
non-controlling interest   (807 )   (2,580 )    
non-controlling interest related to D&A and impairment   (280 )   1,529      
    15,829     81,488      
         
Adjusted EBITDA $ 18,382   $ 21,100   -13 %  
Adjusted EBITDA Margin (2)   54 %   49 %    
         
Adjusted EBITDA: (1)        
(000's)        
  For the Year Ended December 31,  
    2020     2019   % Change  
         
GAAP Operating Income (Loss) $ 67,601   $ (31,532 )    
Add:        
stock-based compensation expense   804     971      
depreciation and amortization   1,196     1,816      
gain on sale of trademarks and investments   (75,705 )   -      
contract asset write offs, net   837     3,769      
impairment charges   54,722     93,966      
special charges   11,816     19,868      
non-controlling interest   (4,362 )   (9,597 )    
non-controlling interest related to D&A and impairment   (1,776 )   1,510      
    (12,468 )   112,303      
         
Adjusted EBITDA $ 55,133   $ 80,771   -32 %  
Adjusted EBITDA Margin (2)   51 %   54 %    
         
         

Balance Sheet and Liquidity:

(000's) December 31, 2020   December 31, 2019  
Cash Summary:        
Unrestricted Domestic, Canada and China (Wholly Owned) $ 29,477   $ 29,144  
Unrestricted Luxembourg (Wholly Owned)   12,832     17,023  
Unrestricted in consolidated JV's   7,488     9,298  
Restricted Cash   9,380     15,946  
Total Cash $ 59,177   $ 71,411  
         
Debt Summary:        
Senior Secured Notes due January 2043* $ 317,856   $ 338,130  
Variable Funding Note due January 2043   100,000     100,000  
5.75% Convertible Notes due August 2023   94,430     94,430  
Senior Secured Term Loan due August 2022 **   99,862     175,600  
Payroll Protection Plan Loan   1,307     -  
Total Debt (Face Value) $ 613,455   $ 708,160  
         
*- The legal final maturity of the Securitization Notes is in January of 2043, as the Company did not repay or refinance the Securitization Notes prior to the anticipated repayment date. Therefore, beginning in January 2020, the Company is no longer required to make previously designated contractual principal payments. Future principal payments are formulaically based on a percentage of receipts of royalty revenue, and as such are subject to market factors outside of the Company’s control. There can be no assurance that all or any future principal payments projected for the Senior Secured Notes will be made in accordance with the projections provided.  
**- The Senior Secured Term Loan Balance at March 31, 2020 is approximately $83 million, reflecting the required principal repayment from the proceeds of the Lee Cooper China sale and the regularly scheduled principal payment on March 31, 2021.  

Fiscal 2021 Outlook

Due to the impact that COVID-19 is having across the globe, and the rapid and continuous economic developments, we are not providing guidance for fiscal year 2021 at this time. The impact of COVID-19 on our business could be material to our operating results, cash flows and financial condition. Due to the evolving and uncertain nature of this situation, we are not able to estimate the full extent of the impact on Iconix’s operating results, cash flows and financial condition. We will provide additional updates as the situation warrants.

About Iconix Brand Group, Inc.

Iconix Brand Group, Inc. owns, licenses and markets a portfolio of consumer brands including: CANDIE'S ®, BONGO ®, JOE BOXER ®, RAMPAGE ®, MUDD ®, MOSSIMO ®, LONDON FOG ®, OCEAN PACIFIC ®, DANSKIN ®, ROCAWEAR ®, CANNON ®, ROYAL VELVET ®, FIELDCREST ®, CHARISMA ®, STARTER ®, WAVERLY ®, ZOO YORK ®, UMBRO ®, LEE COOPER ®, ECKO UNLTD. ®, MARC ECKO ®, ARTFUL DODGER ®, and HYDRAULIC®. In addition, Iconix owns interests in the MATERIAL GIRL ®, ED HARDY ®, TRUTH OR DARE ®, MODERN AMUSEMENT ®, BUFFALO ® and PONY ® brands. The Company licenses its brands to a network of retailers and manufacturers. Through its in-house business development, merchandising, advertising and public relations departments, Iconix manages its brands to drive greater consumer awareness and brand loyalty.

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of the federal securities laws. Such forward-looking statements include projections regarding the Company's beliefs and expectations about future performance and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek" and similar terms or phrases. These statements are based on the Company's beliefs and assumptions, which in turn are based on information available as of the date of this press release. Forward-looking statements involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement and could harm the Company's business, prospects, results of operations, liquidity and financial condition and cause its stock price to decline significantly. Many of these factors are beyond the Company's ability to control or predict. Important factors that could cause the Company's actual results to differ materially from those indicated in the forward-looking statements include, among others: the occurrence of any strategic transaction and the impact of any potential strategic transaction, including acquisitions or dispositions, the ability of the Company's licensees to maintain their license agreements or to produce and market products bearing the Company's brand names, the Company's ability to retain and negotiate favorable licenses, the Company's ability to meet its outstanding debt obligations, the impact of COVID-19 on our and our licensees’ business, results of operations, financial condition and liquidity and the impact of COVID-19 on global production, manufacturing, distribution and sales and the events and risks referenced in the sections titled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent Quarterly Reports on Form 10-Q and in other documents filed or furnished with the Securities and Exchange Commission. Our forward-looking statements do not reflect the potential impact of any acquisitions, mergers, dispositions, business development transactions, joint ventures or investments we may enter into or make in the future. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements are made only as of the date hereof and the Company undertakes no obligation to update or revise publicly any forward-looking statements, except as required by law.

Media contact:John T. McClain  Executive Vice President and Chief Financial Officer  Iconix Brand Group, Inc.  jmcclain@iconixbrand.com212-730-0030

Unaudited Consolidated Statement of Operations(000’s, except earnings per share data)

    Three Months Ended     Three Months Ended     Year Ended     Year Ended    
    December 31,2020     December 31,2019     December 31,2020     December 31,2019    
Licensing revenue   $ 33,888     $ 43,178     $ 108,576     $ 148,984    
Selling, general and administrative expenses     17,355       23,902       59,398       84,748    
Depreciation and amortization     302       422       1,196       1,816    
Equity (earnings) loss on joint ventures     (90 )     2,276       1,364       (14 )  
Gain on sale of investment                 (1,600 )        
Gain on sale of trademarks                 (74,105 )        
Asset impairment     62       1,766       62       1,766    
Investment impairment     2,362       9,613       19,607       26,613    
Trademark impairment     11,344       65,587       35,053       65,587    
Operating income (loss)     2,553       (60,388 )     67,601       (31,532 )  
Other expenses (income):                                  
Interest expense     15,445       13,521       67,694       56,921    
Interest income     (2 )     (102 )     (52 )     (360 )  
Other loss, net     1,718       12,116       3,570       5,291    
Foreign currency translation loss     974       98       1,570       858    
Other expenses – net     18,135       25,633       72,782       62,710    
Loss before income taxes     (15,582 )     (86,021 )     (5,181 )     (94,242 )  
(Benefit) Provision for income taxes     (2,244 )     4,429       (2,205 )     5,683    
Net loss     (13,338 )     (90,450 )     (2,976 )     (99,925 )  
Less: Net income attributable to non-controlling interest     806       2,579       4,360       9,597    
Net loss attributable to Iconix Brand Group, Inc.   $ (14,144 )   $ (93,029 )   $ (7,336 )   $ (109,522 )  
                                   
Loss per share:                                  
     Basic   $ (1.06 )   $ (7.94 )   $ (0.60 )   $ (10.37 )  
     Diluted   $ (1.06 )   $ (7.94 )   $ (0.60 )   $ (10.37 )  
Weighted average number of common shares outstanding:                                  
     Basic     13,175       11,716       12,334       10,559    
     Diluted     13,175       11,716       12,334       10,559    

Footnotes

(1) Adjusted EBITDA is a non-GAAP financial measure, which represents operating income excluding stock-based compensation (benefit) expense, depreciation and amortization, impairment charges, special charges related to potential settlement and professional fees incurred as a result of cooperation with the Staff of the SEC, the SEC and related SDNY investigations, internal investigations, the previously disclosed class action and derivative litigations and costs related to the transition of Iconix management. The Company believes Adjusted EBITDA is a useful financial measure in evaluating its financial condition because it is more reflective of the Company's business purpose, operations and cash expenses. Uses of cash flows that are not reflected in Adjusted EBITDA include interest payments and debt principal repayments, which can be significant. As a result, Adjusted EBITDA should not be considered as a measure of our liquidity. Other companies that provide Adjusted EBITDA information may calculate EBITDA and Adjusted EBITDA differently than we do. The definition of Adjusted EBITDA may not be the same as the definitions used in any of our debt agreements.

Adjusted EBITDA Reconciliation For the Three Months Ended December 31, 2020
  GAAP Operating Income   ImpairmentCharges   Special Charges   Gain on sale of Trademarks & Investments   Depreciation & Amortization   Stock Compensation   Contract Asset Impairment   Non-controlling Interest, net   Adjusted EBITDA
($, 000s) 2020   2019     2020 2019   2020 2019   2020   2019   2020 2019   2020 2019   2020 2019     2020   2019     2020   2019  
Women's (2,099)   (27,198)     8,979 35,281   - -   -   -   - -   - -   - -     -   1,056     6,880   9,139  
Men's 5,510   7,103     849 872   - -   -   -   - 13   - -   - -     (1,816)   (3,210)     4,543   4,778  
Home 4,974   (14,709)     - 17,789   - -   -   -   -     - 1   - -     -   -     4,974   3,081  
International 6,052   (1,944)     1,517 11,645   - -   -   -   74 71   - 3   137 136     (413)   1,336     7,367   11,247  
Corporate (11,884)   (23,640)     2,423 11,379   2,513 4,805   -   -   228 339   196 205   - -     1,142   (233)     (5,382)   (7,145)  
Total Income 2,553   (60,388)     13,768 76,966   2,513 4,805   -   -   302 423   196 209   137 136     (1,087)   (1,051)     18,382   21,100  
                                                     
                                                     
                                                     
                                                     
Adjusted EBITDA Reconciliation For the Year Ended December 31, 2020
  GAAP Operating Income   Impairment Charges   Special Charges   Gain on sale of Trademarks & Investments   Depreciation & Amortization   Stock Compensation   Contract Asset Impairment   Non-controlling Interest, net   Adjusted EBITDA
($, 000s) 2020   2019     2020 2019   2020 2019   2020   2019   2020 2019   2020 2019   2020 2019     2020   2019     2020   2019  
Women's 3,652   (961)     19,617 35,281   - -   -   -   - -   - -   63 117     -   1,056     23,332   35,493  
Men's 10,103   24,878     5,197 872   637 -   -   -   4 50   - -   16 (144)     (5,557)   (10,031)     10,400   15,625  
Home 9,486   (4,932)     5,152 17,789   - -   -   -   - -   1 6   5 8     -   -     14,644   12,871  
International 20,621   23,487     5,065 11,645   - -   -   -   272 301   2 14   753 3,788     (1,677)   (1,668)     25,036   37,567  
Corporate 23,739   (74,004)     19,691 28,379   11,179 19,868   (75,705)   -   920 1,465   801 951   - -     1,096   2,556     (18,279)   (20,785)  
Total Income 67,601   (31,532)     54,722 93,966   11,816 19,868   (75,705)   -   1,196 1,816   804 971   837 3,769     (6,138)   (8,087)     55,133   80,771  
                                                     

(2) Adjusted EBITDA margin is a non-GAAP financial measure, which represents Adjusted EBITDA as a percentage of revenue. The Company believes Adjusted EBITDA margin is a useful financial measure in evaluating its financial condition because it is more reflective of the Company's business purpose, operations and cash expenses. Uses of cash flows that are not reflected in Adjusted EBITDA margin include interest payments and debt principal repayments, which can be significant. As a result, Adjusted EBITDA margin should not be considered as a measure of our liquidity. Other companies that provide Adjusted EBITDA margin information may calculate EBITDA margin and Adjusted EBITDA margin differently than we do. The definition of Adjusted EBITDA margin may not be the same as the definitions used in any of our debt agreements.

Iconix Brand (NASDAQ:ICON)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Iconix Brand Charts.
Iconix Brand (NASDAQ:ICON)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Iconix Brand Charts.